Characterization of six base pair deletion in the putative HNF1-binding site of human PXR promoter

被引:39
作者
Uno, Y
Sakamoto, Y
Yoshida, K
Hasegawa, T
Hasegawa, Y
Koshino, T
Inoue, I
机构
[1] Univ Tokyo, Inst Med Sci, Div Genet Diag, Minato Ku, Tokyo 1088639, Japan
[2] Niigata Univ, Grad Sch Med & Dent Sci, Div Resp Med, Niigata, Japan
[3] Nagoya Univ, Sch Med, Dept Internal Med, Showa Ku, Nagoya, Aichi 4668550, Japan
[4] Univ Tokyo, Grad Sch Med, Dept Resp Med, Bunkyo Ku, Tokyo 1138655, Japan
关键词
PXR; hPAR-2; promoter; HNF1; deletion; AIA;
D O I
10.1007/s10038-003-0076-5
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Pregnane X receptor (PXR) regulates transcription of drug metabolism genes such as CYP3A4 and MDR1. Several species of PXR transcripts have been reported, including hPAR-2 with an extended amino-terminus. Database search identified a 6-bp deletion at the putative HNF1 binding element on the proximal region flanking to the hPAR-2 transcription start site. Aspirin-induced asthma (AIA) is a typical drug-induced phenotype due to aspirin or nonsteroidal antiinflammatory drugs, and these drugs are metabolized by CYP2C9 and UGT1A6, which are regulated by PXR. We examined a possible association between the 6-bp deletion variant and AIA; 129 AIA patients and 117 controls were genotyped, and no allelic association was observed. Characterization of the hPAR-2 promoter revealed that the proximal region of 1.5-kb from the transcription start site conferred a promoter activity and that the 6-bp deletion diminished the activity. These results suggest that the putative HNF1 binding element is essential for the transcriptional activity of hPAR-2 and also, that substantial numbers of Japanese are in a deficient state. Because of the biological significance of the 6-bp deletion of PXR, the variant might potentially associate with as yet unknown phenotype.
引用
收藏
页码:594 / 597
页数:4
相关论文
共 18 条
[1]   Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction [J].
Bertilsson, G ;
Heidrich, J ;
Svensson, K ;
Åsman, M ;
Jendeberg, L ;
Sydow-Bäckman, M ;
Ohlsson, R ;
Postlind, H ;
Blomquist, P ;
Berkenstam, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (21) :12208-12213
[2]   SXR, a novel steroid and xenobiotic-sensing nuclear receptor [J].
Blumberg, B ;
Sabbagh, W ;
Juguilon, H ;
Bolado, J ;
van Meter, CM ;
Ono, ES ;
Evans, RM .
GENES & DEVELOPMENT, 1998, 12 (20) :3195-3205
[3]  
Dotzlaw H, 1999, CLIN CANCER RES, V5, P2103
[4]   Identification of the novel splicing variants for the hPXR in human livers [J].
Fukuen, S ;
Fukuda, T ;
Matsuda, H ;
Sumida, A ;
Yamamoto, I ;
Inaba, T ;
Azuma, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 298 (03) :433-438
[5]   Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin [J].
Geick, A ;
Eichelbaum, M ;
Burk, O .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (18) :14581-14587
[6]   The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module [J].
Goodwin, B ;
Hodgson, E ;
Liddle, C .
MOLECULAR PHARMACOLOGY, 1999, 56 (06) :1329-1339
[7]  
Hustert E, 2001, DRUG METAB DISPOS, V29, P1454
[8]   The pregnane x receptor: A promiscuous xenobiotic receptor that has diverged during evolution [J].
Jones, SA ;
Moore, LB ;
Shenk, JL ;
Wisely, GB ;
Hamilton, GA ;
McKee, DD ;
Tomkinson, NCO ;
LeCluyse, EL ;
Lambert, MH ;
Willson, TM ;
Kliewer, SA ;
Moore, JT .
MOLECULAR ENDOCRINOLOGY, 2000, 14 (01) :27-39
[9]   Role of the hepatocyte nuclear factor 4α in control of the pregnane X receptor during fetal liver development [J].
Kamiya, A ;
Inoue, Y ;
Gonzalez, FJ .
HEPATOLOGY, 2003, 37 (06) :1375-1384
[10]   Regulation of multidrug resistance-associated protein 2 (ABCC2) by nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor [J].
Kast, HR ;
Goodwin, B ;
Tarr, PT ;
Jones, SA ;
Anisfeld, AM ;
Stoltz, CM ;
Tontonoz, P ;
Kliewer, S ;
Willson, TM ;
Edwards, PA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (04) :2908-2915